Featured Event

Date Event Details Remind Me
Summary Toggle Sep 12, 2017 11:40 AM EDT

Galectin Therapeutics to Present at the Rodman & Renshaw 19th Annual Global Investment Conference

Upcoming Events

There are currently no events to display.

Archived Events

Date Event Details
Summary Toggle Jul 13, 2017 3:30 PM EDT

Singular Research Summer Conference

Summary Toggle Mar 28, 2017 9:00 AM EDT

Fourth Quarter and Full Year 2016 Financial Results and Business Update

Summary Toggle Mar 15, 2017 11:30 AM PDT

29th Annual ROTH Conference

Summary Toggle Feb 13, 2017 3:00 PM EST

BIO CEO & Investor Conference Webcast Presentation

Summary Toggle Feb 2, 2017 11:30 AM EST

Summary Toggle Dec 15, 2016 1:30 PM EST

Galectin Therapeutics 2016 Annual Meeting of Stockholders - Corporate Update Webcast

Galectin Therapeutics 2016 Annual Meeting of Stockholders - Corporate Update

Webcast to begin at approximately 1:30 p.m. ET on Thursday, December 15, 2016

The webcast may be accessed directly via the following link:

The presentation may also be heard via teleconference by dialing 866-225-1342 (within the United States).

A list of international dial-in numbers can be found here:

The passcode for participants is 8620018752

Please log in approximately 10 minutes before the event to ensure a timely connection.

Summary Toggle Sep 27, 2016 5:30 PM EDT

Business Update Conference Call & Webcast

Participant dial-in number: 1-888-317-6003
Pin number: 4681161
Webcast link:

Summary Toggle Sep 12, 2016 3:50 PM EDT

Rodman & Renshaw 18th Annual Global Investment Conference

Summary Toggle May 17, 2016 9:00 AM EDT

Galectin Therapeutics Business Update Call

Summary Toggle May 21, 2015 12:00 AM EDT

2015 Annual Stockholder Meeting

Galectin Therapeutics (Nasdaq:GALT) hosted a corporate update webcast on Thursday, May 21, 2015, immediately following the business portion of the Company’s Annual Meeting of Stockholders. Peter Traber, M.D., president, chief executive officer and chief medical officer discussed the company’s pipeline of galectin inhibitor compounds and progress in development of treatments for liver fibrosis and cancer. View the video replay:

Summary Toggle May 14, 2014 10:00 AM EDT

2014 Annual Stockholder Meeting

Galectin Therapeutics (NASDAQ: GALT) held a webcast to provide an update following the Company's Annual Meeting of Shareholders. To view a PDF of the document referenced in the webcast, click here.